Jose A. Alvarez-Cardona, MD, FACC, FHFSA, FICOS
Clinical Assistant Professor of Medicine
Leon H. Charney Division of Cardiology
NYU School of Medicine | NYU Langone Health
New York, NY, USA


I am a Clinical Assistant Professor of Medicine in the Leon H. Charney Division of Cardiology at New York University School of Medicine and NYU Langone Health. I specialize in cardio-oncology, cardiac amyloidosis, and advanced heart failure and transplantation.

After graduating in Medicine in 2006, Pietro Ameri completed the residency and received his PhD in 2014 at the University of Genova, Italy. He is now Associate Professor in Cardiovascular Diseases at the University of Genova / IRCCS San Martino Policlinic Hospital, where he directs the Heart Failure and Pulmonary Hypertension clinical programs, as well as a translational research laboratory. Prof. Ameri's primary interest is heart failure. He is also involved in cardio-oncology, especially with respect to the interplay between heart failure, cancer, and anti-cancer therapies. If he was asked to bring a book, a movie, and a song with him on a desert island, today he would pick The catcher in the rye, The big Lebowski, and Hey you.

Soon...

Anita M Arnold, DO, FACC, FIC-OS, MBA
Director: Cardio-Oncology Lee Health, Florida USA
IC-OS Board of Directors, Chair: Education Committee
Provisional Faculty: Orlando College of Osteopathic Medicine (proposed-seeking accreditation)
Assistant Professor of Medicine: Florida State University


Bio:
Dr. Arnold graduated the NY College of Osteopathic Medicine and completed her internal medicine residency at Bryn Mawr Hospital in Philadelphia as the Chief Resident. Her Cardiology Fellowship was at the Cleveland Clinic Foundation in Ohio. She has been involved in clinical trials and was founder and director of the Milwaukee Cardiovascular Research Foundation. One of the leaders in the field of Cardio-Oncology, she founded the Cardio-Oncology program as well as the C-O Transitional Clinic for adolescent cancer patients for Lee Health in Florida.
Dr. Arnold served on the American College of Cardiology Council for Cardio-Oncology and chaired the Advocacy working group. Currently on the Board of Directors for the International Cardio-Oncology Society she chairs the education committee. She is Certified in Cardio-Oncology and is a Section editor for the Journal of Cardiology-Oncology and a reviewer for JACC Cardio-Oncology and American Heart Journal. She is expanding Cardio-Oncology services for the most vulnerable populations, works with the Homeless Coalition, Habitat for Humanity and local food distribution services where she lives in Southwest Florida, USA.

Available Soon..

Short CV:
Degree in Medicine in University of Navarra (2002-2008). Hematology Residency in Gregorio Marañón General University Hospital in Madrid (2009-2013). Consultant in the Hematology Department of Son Espases University Hospital from 2013 until now. Professional experience abroad focused in transplant field in Long Term Follow Up Program in Fred Hutchinson Cancer Center, Seattle-USA (2016). PhD degree from the University of the Balearic Islands (2019). Active member of the Hematological Neoplasms Group of the Balearic Research Institute (IdISBa). Associate professor of the Faculty of Medicine in Balearic University. Lymphoid Working Group Coordinator from the Spanish Group for Hematopoietic Stem Cell Transplantation and Cellular Therapy (GETH-TC) and active member of the Spanish Group for Lymphoma and Autologous Transplantation (GELTAMO).

Social network account:
Twitter: @leyrebento

Krishnan Bhaskaran
Faculty of Epidemiology and Population Health
London School of Hygiene and Tropical Medicine
London UK

Brief Biography Krishnan Bhaskaran is a Professor of Statistical Epidemiology, Wellcome Senior Research Fellow, and Associate Dean for Research in the London School of Hygiene and Tropical Medicine (LSHTM) Faculty of Epidemiology and Population Health. Krishnan has a background in mathematics and statistics, and experience in big data and electronic health records research. He leads the BEYOND Cancer research group at LSHTM, which aims to understand the impact of the cancer diagnosis and treatments on the long-term physical and mental health of the growing numbers of cancer survivors in the population.

Social Media
@krishnan_lshtm (twitter - personal)
@beyondcancer0 (twitter – team)

Anne Blaes is a Professor in Hematology/Oncology at the University of Minnesota where she also serves as the Division Director of Hematology/Oncology/Transplantation. She is the director of Cancer Survivorship Services and Translational Research and co-director of the Screening, Prevention, Etiology and Cancer Survivorship Program within the Masonic Cancer Center. She is an active hematologist/medical oncologist with a special interest in breast cancer, cardiooncology and cancer survivorship. She is a past chair of the American Society of Clinical Oncology Cancer Survivorship Committee. She serves on the planning committee for the San Antonio Breast Cancer Symposium, and she serves on the Global Cardiooncology Society leadership teams, and the American Heart Association Cardiooncology Council.

Christine Brezden-Masley, MD PhD FRCPC
Mount Sinai Hospital, Toronto, Canada

Christine Brezden-Masley, MD PhD FRCPC is a practicing senior Medical Oncologist and the Medical Director of the Cancer Program at Sinai Health System in Toronto, Canada. She is also the Director of the Marvelle Koffler Breast Centre at Sinai Health and holds the Marvelle Koffler Chair in Breast Research. She obtained her PhD in Medical Biophysics at the Princess Margaret Hospital in Toronto and her Medical Degree from the University of Toronto. She is currently an Associate Professor at the Temerty Faculty of Medicine, University of Toronto and an Associate Scientist at the Lunenfeld-Tanenbaum Research Institute, Toronto, Canada. From July 2012-June 2019, Dr. Brezden-Masley was the Division Head of Hematology/Oncology and Co-Director of the Hematology/Oncology Clinical Research Group at St. Michael’s Hospital in Toronto, Canada.

Dr Brezden-Masley is the founder of the COMET (Community Oncologists of Metropolitan Toronto) Clinical Trials Consortium, a web-based virtual network promoting cancer clinical trials throughout the Toronto region. She treats both breast and gastrointestinal (colorectal and gastric cancers) malignancies, which are her major areas of research interest. Her main area of clinical research is cardiotoxicity from cancer therapy and is the Past-President of the Canadian Cardio-Oncology Network (2017-2022). She also serves on the International Cardio-Oncology Society (ICOS) annual summit steering committees and co-chaired the 2022 Global Cardio-Oncology Summit in Toronto. She co-chairs the Junior Mentoring Program JuMP that fosters mentorship/sponsorship of junior medical oncology faculty across Canada and serves on the executive of WinC (Women in Cancer/All in Cancer). She is an advocate for patients and serves as a board member of ReThink Breast Cancer and MyGutFeeling and also serves on the scientific committee for the Colorectal Cancer Resource & Action Network.

Thoracic Tumour Unit, Department of Medical
Oncology Hospital General Universitario Gregorio Marañón
Madrid, Spain

Dr Calles completed his medical degree at the Universidad Autónoma de Madrid in 2004. Since then, he has held a number of positions in Madrid, including a fellowship in Phase 1 trials under Dr Emiliano Calvo at START, in addition to a 2-year research post at the Dana-Farber Cancer Institute in Boston, USA. Since 2016, he has served as a medical oncologist in the Hospital General Universitario Gregorio Marañón, where he also contributes to early-phase trials and translational research.

This is alongside his role as assistant professor at the Universidad Complutense de Madrid. Dr Calles holds membership of a range of professional societies, including ESMO, ASCO and AACR, the Spanish Society of Medical Oncology (SEOM) and the Spanish Lung Cancer Group (SLCG). He currently serves as a faculty member for the Lung and other Thoracic Tumours group with ESMO.

Twitter: @Tony_Calles

Joseph R. Carver, MD, FACC is a Board Certified cardiologist. He is the Founding Editor of the American Journal of Managed Care and was a Senior Corporate Medical Director at Aetna U.S. Healthcare from 1992-2001 where he was responsible for new program development and directed the National Medical Excellence Program.
From 1999-2001, he was Co-chairperson of the New Jersey and Michigan Working Groups that established voluntary agreements among the insurers in those states to cover the routine costs of clinical trial participation for cancer patients. He is one of the Founding Editors of Cardio-oncology Journal.
He currently is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, the Chief Operating Officer of the Abramson Family Cancer Research Institute of the Abramson Cancer Center of the University of Pennsylvania and the Chief of Staff of the Abramson Cancer Center. He is the Emeritus Director of the Thalheimer Cardio-oncology Center at the Abramson Cancer Center and his clinical practice is in the subspecialty of Cardio-oncology. He was the recipient of the IS Ravdin Master Clinician Award at Penn in 2012 and is one of the founding members of Penn Medicine’s Academy of Master Clinicians. He received the ICOS Thomas Force Award in 2019.

Dr Eva M. Ciruelos is Medical Oncologist and Coordinator of the Multidisciplinary Breast Cancer Unit at the University Hospital 12 de Octubre in Madrid, Spain. She is current coordinator of Breast Cancer Unit at HM private hospitals in Madrid. Additionally, she is an Associate Professor in the Department of Medicine at the Complutense University of Madrid Faculty of Medicine since 2008.

Medical degree at the Autonoma University of Madrid (1996), Spain, and Medical Oncology training in Medical Oncology at the University Hospital 12 de Octubre (2001). She received her Doctorate in internal medicine at the Complutense University of Madrid Faculty of Medicine (2004) with the maximun qualification (Sobresaliente Cum Laude). Master in Molecular Oncology by Centro Nacional de Investigaciones Oncologicas (2002-2004) with the maximun qualification.

Since 2008 Dr Ciruelos directs practical activities of 5th and 6th-grade Medicine students ant Hospital 12 de Octubre, and has been mentoring Doctoral Thesis in postgraduate students (Medicine, Biology and Pharmacy Schools) as well as End of Graduate works in senior students at Medicine School, Complutense University.

Dr Ciruelos is the Principal Investigator of several clinical trials and research projects in breast cancer, and has received many public grants from Instituto de Salud Carlos III, Ministerio de Innovacion, Asociacion Española Contra el Cáncer, and many other public and private organisations. Her research is mainly focused in her Laboratory in Medical Oncology – Gyn and Breast Cancer Unit, at Hospital 12 de Octubre, as well as external collaborations with Centro Nacional de Investigaciones Oncológicas (CNIO) and Consejo Superior de Investigaciones Científicas (CSIC) in Spain. She is the current vicepresident (and former President) of the Solid Tumor Intensification (SOLTI) Group and serves on several committees for that organisation. Dr Ciruelos is now taking part of Boards of evaluation of research grants at Instituto de Salud Carlos III and some private research grants.
She is also a member of the scientific Committee of the Breast International Group (BIG) and European Society of Medical Oncology (ESMO) and has been member of the St Gallen Conference Panel since 2017. She is author and reviewer of many Oncology practice guidelines with national (Spanish Society of Medical Oncology) and international impact.
She is member of many Steering Committees of registration clinical trials and author of current national and international guidelines on management of breast cancer.

Dr Ciruelos has contributed to many oncology textbook chapters, and is author or co-author of numerous articles that have been published in indexed journals (www.pubmed.com) focus on breast cancer research; and is currently being considered as national and international KOL on breast cancer.

Nov 2022-Present: Clinical Director of GenesisCare Madrid: San Francisco de Asís, La Milagrosa and Emilio Vargas Hospitals. National Chief of Research, GenesesisCare Spain.
2019-Oct 2022: Associate Head of Radiation Oncology at Quirónsalud Madrid University Hospital, Madrid, Spain and adjunct physician at Hospital La Luz.
2009-2018: Staff physician at Quirónsalud Madrid University Hospital, Madrid, Spain.
Dr. Couñago studied medicine at the Santiago de Compostela University of A Coruña (Spain) in 2004 and completed his residency in Radiation Oncology at the Princesa University Hospital in Madrid (Spain) in 2009. He is Professor of Oncology at the European University of Madrid Medical School, the Spanish School of Radiation Oncology (EEOR), and the Master’s program in Thoracic Oncology at the CEU Madrid University. He is the director of the Master's degree in Thoracic Cavity Neoplasms at the Alfonso X El Sabio University. He is the director of the Masterclass “Radiotherapy in non-small cell lung cancer” organized by GOECP, SEOR and FEOR in the years 2021 and 2022. He is Professor at the Expert in Prostate Cancer organized by Dr. Ivan Henriquez since 2020.
Dr. Couñago is the coordinator of the Spanish Oncological Group for the Study of Lung Cancer (GOECP) and a founding member of the Multidisciplinary Research Group for Radiation Oncology (GIMOR). He is an active member of several other Spanish research groups, including GICOR (Radiation Oncology research group), URONCOR (the Urological Tumours Working Group), GETICA (Spanish Group of Immuno-Biological Therapies in Cancer). He is member of ESTRO (European Society for Radiotherapy and Oncology) and IASLC (International Association for the Study of Lung Cancer).
As principal investigator, he has initiated and conducted several clinical studies in prostate and lung cancer. He has presented more than 1200 papers at scientific conferences, published 97 articles in indexed international journals, and routinely participates in multiple national and international research projects.
He is Associate/Guest Editor of various indexed journals: Frontiers in Inmunology; Biomedecines; World Journal of Clinical Oncology (WJCO); Reports of Practical Oncology and Archivos Españoles de Urologia. He is a reviewer for numerous journals, including the WJCO, RPOR, Clinical & Translational Oncology; Radiation Oncology; and Cancers. His clinical interests include prostate cancer, lung cancer, hypofractionated stereotactic body radiotherapy, multiparametric MRI, PSMA PET/CT, molecular markers, combining radiotherapy with molecular targeting and immunomodulatory agents and Linacs-MRI.

Social network:
Twitter: @fcounago
Linkld: Felipe Couñago MD PhD

Professor Filippo Crea is Director of the Department of Cardiovascular and Pneumological Sciences and Director of the Postgraduate School in Cardiology at the Catholic University in Rome.
He is Editor-in-Chief of the “European Heart Journal” (2020) and ESC Publications Committee Chair. He is Fellow of the American College of Cardiology and of the European Society of Cardiology
In 1992 he received from Professor Rita Levi Montalcini the Newburg Prize for his scientific contribution to the cardiovascular research.
In 2013 he received the Recordati International Prize for achievement in researching the pivotal role of microcirculation in systemic and organ diseases.
He is author of more than 1300 publications with H index of 95.

TWITTER: @ehj_ed

Evandro de Azambuja, MD, PhD, is the Head of the Medical Support Team (Academic Promoting Team) located at the Institut Jules Bordet, HUB, Université Libre de Bruxelles in Brussels, Belgium
Dr. de Azambuja earned his first PhD from the Federal University of Rio Grande do Sul, Porto Alegre, Brazil, in May 2007 and his second PhD from the Université Libre de Bruxelles (U.L.B) in December 2015.
Dr. de Azambuja is a member of different societies including ESMO, ASCO and BSMO. He also has been chairing different ESMO activities such as Fellowship Committee (2018-2022), ESMO Leaders Generation Program (2018-2022).. He is the elected ESMO membership director 2023-2024.
He has (co)-authored about 275 peer-reviewed articles and 15 book chapters. He has been a member of Education and Scientific Committees of the ESMO, ESMO Breast, EBCC and ECCO meetings and invited international speaker in different conferences and countries.

Dr. Andrés j. Daniele is Director of the Department of Cardio-Oncology of the Institute of Oncology "Ángel H. Roffo", University of Buenos Aires. He graduated from La Plata University with a medical degree and completed his fellowship in cardiology at the Favaloro Foundation.

He developed cardio-oncology in Argentina for more than 10 years and is currently president of the Asociación de Cardio-Oncología de la República Argentina and the International CardiOncology - Chapter Argentina. He is also certified in cardio-oncology by ICOS and is editor and reviewer of many journals.

Social Networks
Twitter: @daniele_andres
Instagram: dr.andres.daniele

Professor Rudolf A. de Boer
Cardiologist & Chair of Cardiology
Erasmus MC Rotterdam
Netherlands

Rudolf de Boer is Chair and Professor of Cardiology at the Erasmus MC, Rotterdam, the Netherlands. His clinical and research interests include heart failure, with a specialty in cardiogenetics, cardio-oncology, obesity, diabetes, HFpEF and biomarkers. He has served as the president of the Heart Failure Working Group of the Dutch Society of Cardiology, been a board member of the Heart Failure Association (HFA), and currently is the President of the Dutch Cardiac Society. He has been an associate editor of the European Journal of Heart Failure and now is an associate editor of the European Heart Journal (section Heart Failure).



Social media:
Twitter: @rudolf_deboer
Linkedin: https://nl.linkedin.com/in/rudolfdeboer

Head of the Medical Oncology Section of the Hospital Universitario La Paz in Madrid and Director of the Innovation Unit of the Hospital La Paz Institute for Health Research - IdiPAZ. Associate Professor of Oncology at the Autonomous University of Medicine of Madrid and Co-Director of the Chair of Innovative Medicine.
The main areas of scientific and healthcare interest are focused on the molecular biology of lung cancer and other thoracic tumors, the study of predictive factors of response to cancer treatments using high-throughput techniques and the study of etiopathogenic factors of the disease and supportive care. In particular, he has participated in the clinical development of EGFR and ALK inhibitors, antiangiogenic drugs and immunotherapy in lung cancer. Dr. de Castro has published more than 200 articles in international journals and is a member of ASCO, IASLC and ESMO. He is currently secretary of the board of SEOM (Spanish Society of Medical Oncology).

Social media:
Twitter: @javierDcastro
Instagram: javierdecastro_oncologo
Linkedin: linkedin.com/in/javier-de-castro

Dr. Susan Dent
Biography

Dr. Dent attended McMaster University Medical School in Hamilton, Ontario, Canada and completed her residency training in Internal Medicine and Medical Oncology at the Ottawa Hospital, University of Ottawa, Ontario, Canada. She subsequently completed a post graduate research fellowship in clinical trials at the Canadian Cancer Trials Group (CCTG) in Kingston, Ontario, and was appointed as a staff medical in Thunder Bay, Ontario.
In 2001, Dr. Dent returned to Ottawa, where she specialized in the treatment of breast cancer with a focus on new drug development. In 2008, Dr. Dent, she established a multidisciplinary cardio-oncology clinic in Ottawa and in 2011, she founded the Canadian Cardiac Oncology Network (CONN), a not-for-profit organization devoted to optimization of cancer care for patients without compromising cardiovascular health. In 2015, Dr. Dent launched the Global Cardio-Oncology Summit (GCOS), an annual meeting which now attracts oncologists, cardiologists, and allied health care providers from more than 23 countries.
Dr. Dent is recognized for her efforts in the evaluation of novel cancer treatments for breast cancer while gaining a better understanding of the impact of these treatments on cardiovascular health. She is recognized as a global leader in cardio-oncology. She has travelled extensively around the world sharing her knowledge and expertise on cancer therapy related cardiovascular toxicity. She continues to work and build relationships with global organizations interested in cardio-oncology including: European Society of Medical Oncology, American College of Cardiology, the American Heart Association, and the American Society of Clinical Oncology. Dr. Dent currently serves as President of the International Cardio-Oncology society (ICOS), an organization dedicated to bringing cardiologists, oncologists, and allied health care providers together, to improve the clinical care of patients and save lives.
In September 2018, Dr. Dent accepted a staff position at Duke University as a breast cancer medical oncologist, Co-Director of Cardio-Oncology, and Associate Director of Breast Cancer Clinical Research. Twitter: @sdent_duke

Anecita Fadol Short Bio

Anecita Fadol, PhD, RN, FAANP, FAAN, FHKAN, is a Nurse Practitioner and Associate Professor in the departments of Nursing and Cardiology at the UT MD Anderson Cancer Center in Houston, Texas. Dr. Fadol is a nursing pioneer in cardio-oncology, and her extensive and unique expertise has been recognized nationally and internationally. She has written numerous book chapters, published in peer-reviewed journals, and is the editor of the “Cardiac Complications of Cancer Therapy”. Her program of research is on cardiotoxicity and included the development and validation of the MD Anderson Symptom Inventory-Heart Failure (MDASI-HF) instrument, which was subsequently translated to Chinese and Spanish. She is the chair of the nursing working group of the International Cardio-Oncology Society. Dr. Fadol is a fellow of the American Academy of Nurse Practitioners, American Academy of Nursing, and an Honorary Fellow in Cardiac Nursing by the Hong Kong Academy of Nursing.

Twitter: afadol1

Dr. Michael Fradley is an Associate Professor of Clinical Medicine in the Division of Cardiology at the Perelman School of Medicine at the University of Pennsylvania and serves as both the section chief of the consultative cardiology section and the medical director of the Thalheimer Center for Cardio-Oncology at the University of Pennsylvania. He earned his B.S at Yale University and his MD degree at the Johns Hopkins University School of Medicine. Dr. Fradley completed his residency in internal medicine through the Osler Medical Residency Program at the Johns Hopkins Hospital. He then went on to complete fellowships in both cardiology and electrophysiology at Massachusetts General Hospital. Prior to joining the University of Pennsylvania, he established the cardio-oncology program at Moffitt Cancer Center and the University of South Florida in Tampa. As a trained electrophysioloigst, Dr. Fradley has particular interest in the diagnosis and management of arrhythmic complications associated with traditional and novel cancer therapies. He has published more than 90 manuscripts and is a frequently invited speaker at international meetings. He has served as the co-chair of the Global Cardio-Oncology Summit in both 2018 and 2021and is a member of the IC-OS (International CardioOncology Society) Board of Directors.

Twitter: @dr_mike_fradley

MANUELA FIUZA
Short Curriculum Vitae

Manuela Fiuza is a professor of cardiology and medical cardiologist at the University Hospital Santa Maria (CHLN/FML) in Lisbon, Portugal, where she leads the Outpatient Clinic of Cardiology and the Cardio-Oncology Unit.
She is also the coordinator of the Portuguese Cardio-Oncology Working Group (GECO).
She is a Fellow of the European Society of Cardiology (FESC).
Her areas of interest include non-invasive cardiac imaging, cardio-oncology, preventive cardiology and gerontology.
She has authored or co-authored more than 200 original research articles, abstracts, and book chapters and is a speaker at leading cardiovascular medicine conferences nationally and internationally.

Other information:

MANUELA FIUZA
Cardiologist; MD; PhD
CHLN/FML; Cardiology; Lisbon; Portugal

Social networks:

Linkedin: linkedin.com/in/manuela-fiuza-33707123
Twitter: @ManuelaFiuza3

Valentín García-Gutiérrez qualified in medicine at the University of Granada in 2003.
Hecompleted a residency in haematology and specialised in haemotherapy at the Hospital Universitario Ramón y Cajal, Madrid. He completed his PhD degree and worked on the clinical haematology and bone marrow transplant ward staff, leading the myeloproliferative disorders programs. In 2016 took his position as associate professor of medicine at Universidad de Alcala, Spain.
Prof García-Gutiérrez is or has been principal investigator of more than 25 clinical trials (phases II–IV) investigating chronic myeloproliferative disorders and bone marrow transplantation. He is also coordinator of 6 national clinical trials in chronic myeloid leukemia. His research has appeared in more than 100 international publications, he has contributed to 6 national guidelines, and he has co-authored 10 book chapters. He is a frequently invited lecturer at international and national haematology congresses. Prof García Gutiérrez is currently the President of Spanish Chronic Myeloid Group (GELMC). He has recently appointed as Principal Investigator of "Hematología Traslacional" group in the Instituto Ramón y Cajal de Investigación Sanitaria after receiving his first R&D projects funded through public competitive calls (PI21//00877) in 2021.

Dr Rosario García Campelo, MD, is the Head of Medical Oncology Department, Thoracic Tumor Unit Chair in the University Hospital A Coruña, Spain, and Head of Oncology Research Group, Biomedical Research Institute (INIBIC), A Coruña, Spain. She obtained her medical degree in 1996 at the University of Santiago de Compostela, Spain, and subsequently completed his training in medical oncology in the University Hospital of A Coruña, Spain. She completed her training as a visiting researcher at the laboratory of Molecular Biology of the Germa Hospital Trias i Pujol (Barcelona, Spain), as well as in Moffit Cancer Center (Tampa, Florida).

She is a member of the Board of the Spanish Society of Medical Oncology (SEOM), member of the Board of the Spanish Lung Cancer Group (SLCG) as well as of different scientific societies.

Her current research focuses on the treatment of thoracic tumors, with special interest in novel therapies against lung cancer, and clinical/translational research, with an active participation in national and international clinical trials.

Twitter: @charocampelo

Soon...

Professor Diana A Gorog MB BS, MD, PhD, FRCP, FESC
Professor of Cardiovascular Medicine & Consultant Cardiologist
University of Hertfordshire, East and North Hertfordshire NHS Trust, & Imperial College
Hertfordshire & London, United Kingdom

Professor Diana Gorog holds academic appointments at the University of Hertfordshire and at the National Heart and Lung Institute of Imperial College, London, and is a full-time consultant cardiologist at East and North Hertfordshire NHS Trust, UK.
She graduated in Medicine from St. Bartholomew’s Medical School, University of London and undertook clinical training in major London teaching hospitals including the Hammersmith, Royal Brompton, St Mary’s, and Royal Free hospitals. Her research interest focuses on understanding the mechanisms of arterial thrombosis, in particular impaired endogenous fibrinolysis and how that can be detected and treated. She is the Chair Elect of the Working Group on Thrombosis of the European Society of Cardiology.

Zaza Iakobishvili, MD, PhD, FESC, FHFA

Professor of Cardiovascular Medicine,
Faculty of Health Sciences, Ben Gurion University of the Negev
Director of the Community Cardiology Department,
Tel Aviv-Jaffa district of Clalit Health Services
President, Israeli Chapter of International Cardio-Oncology Society
Chairman, Community Cardiology Working Group, Israel Heart Society

Prof. Iakobishvili has established the first dedicated cardio-oncology clinic in Israel in the Rabin Medical Center in 2013. Prof. Iakobishvili chairs the Committee on the Surveillance and Management of Cardio-Oncology Patients of Israel Ministry of Health Council on Management and Prevention of Heart and Vascular Diseases. Now he works on creating outpatient cardio-oncology clinics network within Clalit Health Services to serve cancer survivors and establish cardio-oncology rehabilitation program.

He is actively involved in scientific research and had authored more than 130 papers and book chapters, published in peer-reviewed journals in the field of cardiology, reviews for front-line cardiology journals.

Publication List from the PubMed database

Borja Ibáñez (Madrid, 1975) combines research activities as Scientific Director of the Spanish National Center for Cardiovascular Research (CNIC) with clinical activities as interventional cardiologist at the University Hospital Fundación Jiménez Díaz.

He was trained in Spain and in USA (Mount Sinai Heart, NY). His research is at the verge of basic and clinical arena, mainly in the fields of MI, heart failure and lately to cancer therapy-induced cardiotoxicity. He is the co-PI of the large PESA project, focused on primary prevention of atherosclerosis.

He is PI of several multicenter clinical trial. He served as the Chairperson of the 2017 European Society of Cardiology (ESC) STEMI Clinical Practice Guidelines and is Chairperson of the forthcoming ESC guidelines for Acute Coronary syndromes.

He is PI coordinator of several national and international projects, including H2020-funded grants, highlighting an active ERC consolidator grant called “MATRIX” (Novel mitochondria-targeted therapies for anthracycline-induced cardiotoxicity), and a H2020-HEALTH project called “RESILIENCE”.

He has published more than 350 scientific publications in high-impact journals. His H-index (scholar) is 73, and his works have received more than 50,000 citations.

He has received numerous awards for his scientific merits, including the Banco de Sabadell, Constantes y Vitales, Princesa de Girona, and Fundación Jesús Serra among others.

twitter: @borjaibanez1

Kalliopi Keramida, PhD, FESC, FHFA, F-ICOS, is a Consultant Cardiologist in General Anti-Cancer, Oncological Hospital Agios Savvas, Athens, Greece. She is board certified in Cardio-Oncology by International Cardio-Oncology Society (ICOS) and in Heart Failure by Heart Failure Association (HFA) and she has a special interest in echocardiography. She is the vice president of the Greek Working Group of Cardio-Oncology and a committee member in Cardio-Oncology Study Group of HFA. She is a reviewer in several peer-reviewed journals, Associate Editor in ESC Heart Failure and Section Editor in Archives of Medical Science.

twitter: @keramidakallio3

Gerry Lee is an academic nurse and is currently a Reader in Advanced Clinical Practice at King’s College London. Her research interests are cardiovascular disease and in particular, optimising health in chronic long-term conditions using shared-decision masking and digital technology.
In 2018, she established a nurse-led rapid access clinic for patients with suspected atrial fibrillation with this includes reviewing patients who developed AF following the commencement of cancer therapies. Dr Lee is the nursing and allied health representative for the Association of Cardiovascular Nursing and Allied Professionals on the ESC Council for Cardio-Oncology. She has published over a 130 peer reviewed papers and led the work on the quality indicators for cardiac-oncology patients with cardiology and oncology colleagues.

For conference material

Dr Gerry Lee (PhD)
Reader in the Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King’s College London.

Link to profile: https://kclpure.kcl.ac.uk/portal/gerry.lee.html

Social media: @gerrythecynic (Twitter)
LinkedIn: https://www.linkedin.com/in/geraldine-gerry-lee-1a48575/?originalSubdomain=uk

Jennifer Liu, MD
Chief of Cardiology
Memorial Sloan Kettering Cancer

I am a cardiologist with an expertise in echocardiography. My research and clinical interests focus on the application of advanced echo imaging to better understand the pathophysiology of cancer related heart disease, and to develop strategies that will allow early detection of cardiotoxicity and initiation of cardioprotective intervention to minimize interruption of cancer treatment. I also specialize in amyloid heart disease and have a long standing relationship with the hematology/oncology service to provide care to patients with AL amyloidosis.

@JLiu_MSKCardOnc

Professor Charlotte Manisty is Director of Cardio-Oncology at Barts Heart Centre, and Professor of Cardiology at University College London. She is currently Chair of the Society of Cardiovascular MRI Cardio-Oncology group and Secretary of the British Cardio-Oncology Society. She is on the Board of the International Society for Cardiovascular MRI, and is Principal Investigator on multiple clinical research studies in cardio-oncology and cardiovascular imaging.

Twitter: @dr_manisty

Pilar Martín Fernández is Assistant Professor at the Spanish National Cardiovascular Research Center (CNIC) in Madrid. Dr. Martin leads a line of research in the field of Cardio-Immunology, focused on the role of T cells and microRNAs in the pathophysiology of myocarditis, atherosclerosis and myocardial infarction in preclinical models and humans. Her contributions to the cardio-immunology field as a senior author have been published in high-impact journals, including the New England Journal of Medicine, Circulation, the Journal of Clinical Investigation, European J Heart Failure, or the Journal of Autoimmunity. Her group has developed two patents: "Method for diagnosing cardiomyopathies" and "Kit for the diagnosis of acute myocarditis".

Social networks:
Twitter: @PilarMartinFern
https://orcid.org/0000-0002-2392-1764

Head of cardiac imaging section. Cardiology department. Reina Sofia University Hospital. Cordoba (Spain)

Academic training:
Bachelor of Medicine and Surgery (Cadiz University 1986).
Pre-doctoral grant for the training of Research Personnel. Ministry of Education and Science. 1986.
PhD degree at the Cordoba University, 1997.
Multiple national and international publications in impact journals

Current professional status:
Physician Specialist in the Cardiology Area. Start date: 1993.
Head of cardiac imaging section. Start date: 2018
Organization: Andalusian Health Service.
Center: Reina Sofia University Hospital. Cordoba
Department: Cardiology.

Other charges:
President of the Andalusian Society of Cardiology
President of the Cardioncology working group of the Andalusian Society of Cardiology
Member of the Clinical Research Committee Maimonides Institute for Biomedical Research (IMIBIC), Cordoba, Spain. Start date:2020
Leader Member of ICOS (International Society of Cardioncology) within the Spanish Chapter.
Certified in Cardioncology by the International Society of Cardioncology in 2020

Twitter: @MesaLola
Instagram: loladoloresmr

Cardiology Faculty at University Hospital Puerta de Hierro Madrid since 2015. Cardio-Oncology Coordinator at this centre since 2016
Member of The Advanced Heart Failure and Heart Transplant Unit.
Member of the Cardio-Oncology working group at the Spanish Society of Cardiology and of the International Cardio-Oncology Society

Twitter: @Cristina_Mitroi

Pedro Moliner, MD, PhD. Cardiologist. L’Hospitalet de Llobregat, Barcelona.
Head of the Cardio-Oncology Unit in Bellvitge University Hospital with the Catalan Institute of Oncology. Cardiology Consultant at the South Metropolitan Barcelona Integrated Heart Failure Programme. Postdoctoral researcher in the BIOHEART Cardiovascular Disease Research Group. IC-OS Board Certification. Coordinator of the Cardio-Oncology Group of the Catalan Society of Cardiology. Member of the Cardio-Oncology working group of the Spanish Society of Cardiology and the Council of Cardio-Oncology of the European Society of Cardiology. Member of the editorial board of the European Journal of Internal Medicine. Collaborating professor in the Medicine degree at University of Barcelona.

Twitter: @PeterMoliner
Linkdin: linkedin.com/in/pedro-moliner-borja-01761895

Tomas G. Neilan, MD, MPH

Dr. Neilan is an Associate Professor of Medicine at Harvard Medical School, a cardiologist at MGH, the director of the Cardio-Oncology Program at MGH and the co-director of the Cardiovascular Imaging Research Center.

He holds the Michael and Kathyrn Park Chair in Cardiology. He is a physician scientist and a board-certified cardiologist. He completed his medical school training at University College Dublin Medical School, his clinical training in Internal Medicine and Cardiology at the Mater Hospital in Dublin and repeated his training in Internal Medicine and Cardiology at MGH. He has also competed advanced training in echocardiography at MGH, a clinical and research fellowship in cardiac MRI at BWH, and a Master’s in Public Health at the Harvard School of Public Health. His career has had two major focuses: 1) Understanding how we can improve the cardiovascular care of patients with cancer and 2) The use of advanced imaging to better understand and characterize cardiovascular disease. He has authored or co-authored more than 150 original manuscripts, 50 review articles, has presented over 400 abstracts at international meetings, and has lectured at major national and international meetings. Dr. Neilan has been awarded the “de Gunzburg Family Endowed Scholar in Cardiology”, The Locke Award for excellence in medical education and elected as a Senior Fellow to the Oliver Wendell Holmes Society at Harvard Medical School.

Dr. Antonio Pérez-Martínez is a renowned pediatric oncologist and researcher with extensive experience in the field of advanced therapies and hematopoietic progenitor transplantation. He is the Head of the Paediatric Haemato-Oncology Service at the University Hospital La Paz (Madrid), Professor and Chief of the Department of Pediatrics at the Faculty of Medicine of the University Autonoma of Madrid, and Principal Investigator of the Translational Research Group in Childhood Cancer, Haematopoietic Transplantation, and Cell Therapy at the Health Research Institute University Hospital La Paz. He completed three postdoctoral stays at St Jude Hospital, Tübingen Children's Hospital, and Mason Cancer Center. He has published over 170 scientific articles and holds two patents. He is a reference in the treatment with NK cells, in haematopoietic progenitors transplantation and in CAR-T advanced therapies. He collaborates with national and international networks and has received various awards for his contributions to the field of pediatric oncology.

Twitter: @antonioper_mar
Linkedin: @antonio-pérez-martínez

Charles Porter, MD, FICOS
Professor of Medicine
Director of Cardiooncology
University of Kansas Medical Center
Kansas City Kansas USA

Dr. Porter’s experience in heart failure and cardiac transplantation began with his contributions to the establishment of the first heart transplant program in Western Missouri in 1985. His 2005 collaborations with the breast oncologists at the University of Kansas Cancer Center facing cardiotoxicity with trastuzumab became the foundation of the CV medicine cardiooncology program that he has directed since its creation. He became the first American Vice-President of ICOS in 2009 and continues to serve on ICOS Committees and on the editorial advisory board of Cardiooncology Journal as well as the editorial advisory committee of JACC CardioOncology. His cardiooncology publications include the 2022 inaugural discussion of the concept of Permissive Cardiotoxicity in JACC CardioOncology which will be the subject of his presentation at GCOS 2023 in Madrid.

Twitter: @charlesporter99
Doximity: Charles Porter MD

Born in Salamanca, Spain, in 1966

Academic backgroung: (1984-1990) Degree in Medicine at University of Salamanca. (1998) PhD Degree in Medicine, University of Salamanca. (1992-1995) Residency training in Radiation Oncology, University Hospital Doce de Octubre, Madrid.
Complementary clinical training: (1994) Hospital Royal Marsden, London, UK and (2001) Memorial Sloan Kettering Cancer Center, New York, USA.
Professional experiences: (1996-2000) Attending radiation oncologist, Radiosurgery Unit, San Francisco de Asís, IMO, Madrid. (1996-2000) Attending radiation oncologist, Fundación Jiménez Díaz, Madrid. Since 2006 Head of Radiation Oncology Department of HM Hospitales, Madrid.
Areas of interes: Broad clinical experience on advanced radiation oncology tecnhiques: Stereotactic Radiosurgery, SBRT, IMRT, VMAT and IGRT and SGRT. Specific clinical interes on brain, liver, lung, pancreatic, prostate tumors and oligometastatic patients.
Academic and scientific activities: Since 2008 Assistant Professor at the University of Madrid, CEU San Pablo- School of Medicine. Director of PhD Disertations, and Final Medical Deggree Proyects. Teacher of numerous Master´s Degrees: Internacional Master of Radiosurgery. at Complutense University of Madrid, Internacional Master of Clinical Oncology and International Master of Radiosurgery SBRT at Francisco de Vitoria University, Madrid and Online Master of Radiation Oncology, Tech University. Since 2018 ESTRO-School Teacher and since 2019 Co-Chair of IMRT/VMAT and other conformal techniques ESTRO- School Course. Teacher and Director of numerous Courses and Conferences. Numerous presentations and comunications in national and international Conferences and Symposiums. (2011-2015) Coordinator of SBRT Spanish Group of SEOR.
Memberships: (2012-2016)-Member of the Board of Director of the Spanish Society of Radiosurgery (SER). Since 2021- Vicepresident of SEOR (Spanish Radiation Oncology Society)

Linkedin: http://linkedin.com/in/m-carmen-rubio-rodríguez-m-d-phd-2149879a
Twitter: @Mamen_RubioR

Fadi N. Salloum, PhD, FAHA, FAPS
Professor of Medicine (Cardiology)
Natalie N. and John R. Congdon Sr. Endowed Chair in Cardiology
Associate Chair for Research, Department of Internal Medicine
Associate Director of Research Mentoring & Preclinical Science, VCU Health Pauley Heart Center
School of Medicine
Virginia Commonwealth University
Richmond, Virginia
U.S.A.

Dr. Salloum has served as PI or co-investigator on numerous National Institutes of Health, American Heart Association, and Industry-funded grants and currently leads a multi-disciplinary basic science and translational research program funded by the NIH and AHA for the last 13 years, with the most recent funding of the prestigious 7-year NHLBI R35 award through 2027 (R35HL155651). The lab’s focus is on the role of novel or ‘repurposed’ drugs in cardioprotection against cancer therapy-related injury and adverse cardiac remodeling/failure through suppression of sterile inflammation, mitochondrial dysfunction, and protein aggregates that may lead to cardiomyopathy.

Twitter: @SALLOUMFN
LinkedIn: Fadi N. Salloum

Carolina Silva, MD, PhD
Board certified cardio-oncologist
Associate researcher, Brazilian Clinical Research Institute
Associate Professor, Galen Academy
Sao Paulo - Brazil

Twitter: @carolinasilvaMD Instagram: @dra_carolinasilva

Dr Susannah Stanway MBChB MSc FRCP MD
UK Global Cancer Network and London Global Cancer Week
Biography March 2023 for GCOS, Madrid


Dr Susannah Stanway is a breast medical oncologist in London. She is currently on a break from clinical practice at the Royal Marsden Hospital to focus on her work on Global Oncology. She is co-convenor for London Global Cancer Week (https://www.lgcw.org.uk) and has co-set up the UK Global Cancer Network (https://www.ukgcn.org). She leads a group as part of the ECO’s Inequalities Network, is on the Global Policy Group at ESMO, lectures about cancer and Global Health at the Institute of Cancer Research, London School of Hygiene and Tropical Medicine and University College London. She has been research active in Africa with GCRF grants. She speaks locally, nationally and internationally and has published in peer reviewed journals.

Twitter: @SusannahStanwa1 LinkedIn: Susie Stanway

Sebastian Szmit M.D., Ph.D.,
Associate Professor of Medicine
Head of Department of Cardio-Oncology
Centre of Postgraduate Medical Education

Sebastian Szmit graduated from the Military Medical Academy in Poland (2002).
From 2002 to 2012 he worked at the Military Institute of Medicine in the (1) Emergency Department, (2) Department of Internal Medicine and Cardiology, (3) Department of Oncology.
From 2012 to 2022 he was employed by the Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology as cardiologist consultant of the Department of Oncology at the European Health Centre, Otwock.
Since 2016, he has been the Research Coordinator of the Cardio-Oncology Section of the Polish Lymphoma Research Group and the scientific director of the course entitled "Oncology in Cardiology" - obligatory training within specialty program in cardiology in Poland.
In December 2022 he was appointed the Head of the Department of Cardio-Oncology, Centre of Postgraduate Medical Education at the Institute of Hematology and Transfusion Medicine & Consultant Cardiologist of the Clinic of Oncological Diagnostics and Cardio-Oncology at the Maria Sklodowska-Curie National Research Institute of Oncology (Warsaw, Poland).

Social network accounts:

CardioOncology Poland
@oncology_cardio
https://www.facebook.com/CardioOncologyPoland

Professor Peter van der Meer, MD, PhD
University Medical Center Groningen, Netherlands
Peter van der Meer is a cardiologist, chair of the Department of Experimental Cardiology and director of the Coronary Care Unit at University Medical Center Groningen. He is also a Professor of Heart Failure and Translational Cardiology at the University of Groningen.
Professor van der Meer received both his MD and PhD cum laude from the University of Groningen, and completed a postdoctoral fellowship at Harvard Medical School, Boston, MA, USA. He authored >300 manuscripts, has an H-index of 77 and was member of the 2022 ESC CardioOncology guidelines. He is a member of several steering committees of large phase 3 trials. His research is funded by national and international grants including an ERC StG and CoG grant. His research group consists of PhD students and post-docs with various backgrounds (biologists, medical doctors and biomedical-engineers) working on translational research topics to bridge the gap between bench and bedside. Professor van der Meer’s research focusses on understanding the susceptibility to develop heart failure and on exploring novel treatment targets and therapies.

Twitter: @p_van_der_meer

Lucrecia Yáñez obtained her grade in Medicine and her Physician Doctorate in 2000 and 2015, respectively, at the University of Cantabria.
She became specialist in Hematology at the University Hospital Marqués de Valdecilla, in 2005. She is Associate Professor at University of Cantabria since 2007.

Since 2006, I work at the University Hospital Marqués de Valdecilla focused on the field of Chronic Lymphocytic Leukemia, Aplastic anemia, and cellular therapy, mainly allogeneic stem cell transplantation and CAR-T cell therapy. I have improved my knowledge in CLL and cellular therapy after staying 6 months, respectively, at the National Center for Oncological Research (CNIO) and the Memorial Sloan Kettering in New York.

Currently, I am member of the board of the Spanish Society of Hematology (SEHH) and the Spanish Group of CLL (GELLC).

Lucrecia Yáñez, MD, PhD
Hematology Department.
University Hospital Marqués de Valdecilla-IDIVAL, Santander
University of Cantabria


@DrLucreciaYSS

Magdalena Zaborowska- Szmit, M.D., Ph.D.,

Researcher at the Department of Lung Cancer and Thoracic Tumors,
Maria Sklodowska-Curie National Research Institute of Oncology,

-------------------------------------------------------------

Magdalena Zaborowska-Szmit graduated from the Faculty of Medicine at the Medical University in Bialystok, Poland (2008). She completed the postgraduate internship at the Military Institute of Medicine in Warsaw, Poland. She became a specialist in clinical oncology in 2017, passing the exam with the best result in Poland.

Since 2017 she has been working as a scientific assistant at the Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Poland.

In 2021 she finished Ph.D. project entitled "Evaluation of prognostic and predictive factors among patients with locally advanced non-small cell lung cancer treated with sequential chemoradiotherapy“

She is a Member of European Society for Medical Oncology (ESMO), International Cardio-Oncology Society (IC-OS), member of Polish Society of Clinical Oncology and Polish Lung Cancer Group.

She is focused on (1) chemoradiotherapy in lung cancer, (2) personalized therapy in lung cancer, (3) cardio-oncology in lung cancer.

Social network account:
https://www.facebook.com/mzaborowska3/

Dr. Zatarain-Nicolás MD, PhD. Clinical cardiology and heart failure specialisth. Coordinator of the Cardio-oncology multidisciplinary group at University Hospital Gregorio Marañón in Madrid. Member of the ICOS advocacy commettee, Cardio-oncology working group of Spanish Society of Cardiology and member of the ESC cardio-oncology council.

SoMe: @EduZatarain